コンテンツへスキップ
Merck
  • Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery.

Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery.

Tissue engineering. Part A (2014-01-15)
Zeeshan H Syedain, Lee A Meier, Mathew T Lahti, Sandra L Johnson, Robert T Tranquillo
要旨

The performance of completely biological, decellularized engineered allografts in a sheep model was evaluated to establish clinical potential of these unique arterial allografts. The 4-mm-diameter, 2-3-cm-long grafts were fabricated from fibrin gel remodeled into an aligned tissue tube in vitro by ovine dermal fibroblasts. Decellularization and subsequent storage had little effect on graft properties, with burst pressure exceeding 4000 mmHg and the same compliance as the ovine femoral artery. Grafts were implanted interpositionally in the femoral artery of six sheep (n=9), with contralateral sham controls (n=3). At 8 weeks (n=5) and 24 weeks (n=4), all grafts were patent and showed no evidence of dilatation or mineralization. Mid-graft lumen diameter was unchanged. Extensive recellularization occurred, with most cells expressing αSMA. Endothelialization was complete by 24 weeks with elastin deposition evident. These completely biological grafts possessed circumferential alignment/mechanical anisotropy characteristic of native arteries and were cultured only 5 weeks prior to decellularization and storage as "off-the-shelf" grafts.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
モノクロナール抗β-アクチン マウス宿主抗体, clone AC-15, ascites fluid
Sigma-Aldrich
抗アクチン、α-平滑筋抗体、マウスモノクローナル, clone 1A4, purified from hybridoma cell culture
Sigma-Aldrich
抗CD3, T細胞 ウサギ宿主抗体, whole antiserum